Authored by: Jon Carson, Iain Farrance, John Getz, and Jon A. Rowley, RoosterBio, Inc. On 31-December-2019, Chinese officials alerted the World Health Organization of an outbreak of pneumonia cases in ... More
Authored by: Kathy Williams, Vice President of Quality Assurance/Regulatory Affairs and Caitlin Hansen, Director of Quality Control RoosterBio Quality Excellence: we nurture a hard-working innovative culture where quality begins at ... More
Authored by Katrina Adlerz, Ph.D., Scientist, Analytics, Product & Process Development & Josephine Lembong, Ph.D., Scientist, Analytics, Product & Process Development The 2019 International Society for Cell and Gene Therapy (ISCT) ... More
Authored by Josephine Lembong, Ph.D., Scientist, Product & Process Development & Jon Rowley, Ph.D., Founder and Chief Product Officer, RoosterBio Inc. Previously, we published a blog post on estimating hMSC ... More
Authored by Josephine Lembong, Ph.D., Scientist, Product & Process Development & Jon A. Rowley, Ph.D., Founder and Chief Product Officer, RoosterBio Inc. Jon Rowley, RoosterBio’s Founder and Chief Product Officer, gave a talk at ... More
Contributed by: Timothy R. Olsen, Ph.D. – Sr. Scientist, Process and Product Development at RoosterBio Inc. After the National Institute for Standards and Technology (NIST) identified upcoming challenges in the U.S. ... More
Last week was the 4th Annual IBC Cell Therapy Bioprocessing Conference. IBC (home of the BioProcess International conference) was the first conference organizer to dedicate a focused meeting on Cell Therapy Manufacturing Technologies 4 ... More
Mesenchymal Stem Cells (MSCs) are widely studied in academic circles and an attractive cell source for clinical applications. MSCs not only possess the ability to self-renew and differentiate to a number ... More